<DOC>
	<DOCNO>NCT01805102</DOCNO>
	<brief_summary>PIF : biomarker pregnancy , miscarriage , premature birth , preeclampsia , placenta accreta . Except serum hCG , pregnancy-complication marker widely employ predict need medical intervention . Since circulate PIF present early throughout viable pregnancy , may represent specific biomarker candidate . PIF level analyze serum pregnant woman range setting : ) follow IVF ; b ) index pregnancy woman history recurrent pregnancy loss , c ) index pregnancy woman history placenta mediate complication : intrauterine growth restriction , spontaneous idiopathic preterm delivery , preeclampsia ; ) index pregnancy woman evidence abnormal placentation , namely placenta accreta related condition .</brief_summary>
	<brief_title>Correlation Between PIF Maternal Serum Levels Pregnancy Outcome</brief_title>
	<detailed_description>We assess PIF prospectively maternal serum throughout viable pregnancy order ass performance characteristic predict viability . More 250 pregnancy IVF study control patient . This PIF longitudinal pregnancy follow compare observed woman risk pregnancy complication , previous pregnancy . One objective also define PIF biomarker pregnancy outcome . Then , also assess PIF level maternal serum woman pregnancy complication like miscarriage , preeclampsia , placenta accreta , preterm birth intrauterine fetal growth restriction . Our objective evaluate PIF maternal serum level index pregnancy woman previous pregnancy complication ( miscarriage , preeclampsia , intrauterine fetal growth restriction , preterm birth ) list consider risk pregnancy complication recurrence . Data compare control woman ( spontaneous pregnancy , singleton gestation , medical treatment , normal delivery ) pregnant woman SET MET IVF . Prospectively , include patient previous pregnancy complication 100 control woman 200 woman IVF cycle , 36 month . PIF assessment perform use specific antibody mark fluorescent dye , Luminex® reader . - PIF predictive value pregnancy prognosis For woman , 5 routine blood draw conduct . The first one occur SET MET ( multiple embryo transfer ) woman conceive via IVF result successful ongoing pregnancy . Specifically , PIF level maternal serum evaluate 5 week embryo transfer . In woman history previous pregnancy complication control one , maternal blood draw obtain upon diagnosis pregnancy , first trimester . The remainder blood draw ( three per patient ) obtain time routine antenatal blood draw ( typically 10-13 week first trimester screen 15-20 week MSAFP assessment ; 24-28 wks glucose screen complete blood count ) . If complication occur , sixth blood draw do diagnosis time . Definitions : Preeclampsia define hypertension ( sustained elevation systolic BP least 140 mmHg and/or diastolic BP least 90 mmHg least 6 hour ) association proteinuria ( 300 mg/24 hour ) concentration least 30 mg/dl ( least 1+ dipstick ) least 2 random urine sample collect least 6 hour apart . Intrauterine fetal growth restriction define birth weight ≤10 % percentile gestational age , unrelated malformation , karyotype abnormality , obvious fetal infection uterine malformation . IUGR ascertain hospital record relate current pregnancy . Miscarriage , fetal loss , define spontaneous loss pregnancy prior 20 week gestation , recurrent pregnancy loss define 2 failed pregnancy ( document ultrasound histological exam ) . Unexplained fetal death define death ≥ 20 wks gestation unrelated major malformation , karyotype abnormality , maternal fetal infection , maternal uterine cervical malformation . Fetal death ascertain hospital record relate current pregnancy . The research nurse complete fetal death form , include information autopsy result ( available ) , maternal serology , toxicology , maternal/fetal infection , uterine cervical malformation , fetal/ placental karyotype , isoimmunization . Placenta accreta define direct apposition placental villus myometrium . Placenta accreta classify accord degree myometrium penetrate placental villus ( KhongTY . J ClinPathol . 2008 Dec ; 61 ( 12 ) :1243-6 ) . Preterm birth define spontaneous birth occur 37 complete week gestation , 20 week gestation . Methodology All woman fully inform write consent participate study duly obtain . Maternal serum retrieval Maternal serum collect routine blood draw : - 5 week embryo transfer pregnant woman IVF , woman previous pregnancy complication upon diagnosis pregnancy first trimester ( P1 ) - first trimester screen 10-13 wks ( P2 ) - second trimester analyte screening , 15-20 wks ( P3 ) - screen diabetes , anemia assessment 24-28 wks ( P4 ) - admission labor delivery ( P5 ) - pregnancy complication diagnosis ( P6 ) PIF level evaluation As previously describe Analysis Correlate PIF level maternal serum pregnancy complication . Results PIF detection maternal serum correlate pregnancy outcome , pregnancy complication . Evolution PIF level pregnancy also evaluate . Controls match parity , multiple gestation gestational age blood draw ( +/- 2wks ) . Statistical analysis plan component , ( template provide ) URC Paris Ile de France Ouest As pregnancy complication occur 25 % case , patient number estimate 1350 . 350 pregnancy complication occur study . The sample size provide 5 % precision 30 % event occurrence 5 % standard deviation .</detailed_description>
	<criteria>Inclusion criterion : Women attend perinatal center properly inform willing participate study . Women include participate center previous pregnancy complication pregnant woman IVF ( SET MET ) . PIF level evaluation maternal serum ( P1 5 ) evaluate pregnant woman . Exclusion criterion : Women refuse participate program .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>In vitro fertilization</keyword>
	<keyword>implantation</keyword>
	<keyword>miscarriage</keyword>
	<keyword>live birth</keyword>
</DOC>